What is Acute Coronary Syndrome (ACS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Coronary Syndrome (ACS): Definition and Classification

Acute Coronary Syndrome (ACS) refers to a constellation of clinical symptoms caused by acute myocardial ischemia, typically resulting from disruption (rupture or erosion) of an unstable coronary artery atherosclerotic plaque with associated partial or complete coronary artery thrombosis, leading to diminished blood flow to the myocardium and subsequent myocardial ischemia. 1

Pathophysiology

The pathophysiology of ACS involves:

  • Progressive lipid accumulation and inflammation within atherosclerotic plaque leading to plaque instability
  • Rupture or erosion of the atherosclerotic plaque exposing plaque contents to circulation
  • Activation of the coagulation cascade and subsequent thrombosis
  • Compromise of blood flow to the myocardium, causing ischemia and potential myonecrosis 1

This process typically occurs in the epicardial vessels of the coronary circulation. The pathophysiology is dynamic, and patients can rapidly progress from one clinical condition to another during presentation and initial evaluation. 1

Classification of ACS

ACS includes three related clinical conditions that exist along a continuum of severity:

  1. Unstable Angina (UA):

    • Transient myocardial ischemia with diminished flow
    • No significant myonecrosis (normal cardiac troponin)
    • May show ECG changes but no biomarker elevation 1, 2
  2. Non-ST-segment Elevation Myocardial Infarction (NSTEMI):

    • Partial coronary artery occlusion leading to subendocardial ischemia
    • Elevated biomarkers of myonecrosis (troponin)
    • May show ST-segment depression or T-wave inversion on ECG 1, 2
  3. ST-segment Elevation Myocardial Infarction (STEMI):

    • Complete coronary artery occlusion leading to transmural myocardial ischemia
    • Elevated biomarkers of myonecrosis
    • ST-segment elevation on ECG 1, 2

Diagnostic Criteria

The initial diagnosis and classification of ACS should be based on:

  1. Clinical history and symptoms:

    • Chest discomfort/pain (present in ~79% of men and 74% of women)
    • Associated symptoms: dyspnea, radiation to arms/jaw/back, diaphoresis, nausea 3
  2. ECG findings:

    • NSTE-ACS: New or presumed new horizontal or down-sloping ST-segment depression ≥0.5 mm in ≥2 contiguous leads and/or T-wave inversion >1 mm in ≥2 contiguous leads
    • STEMI: New or presumed new ST-elevation of ≥1 mm in ≥2 anatomically contiguous leads (measured at the J-point) in all leads other than V2-V3, and ≥2 mm in men ≥40 years, ≥2.5 mm in men <40 years, and ≥1.5 mm in women regardless of age in leads V2-V3 1
  3. Cardiac biomarkers:

    • Cardiac troponin (cTn) is the preferred biomarker
    • Serial measurements may be necessary 1, 3

Comparative Features of ACS Subtypes

Feature Unstable Angina NSTEMI STEMI
Symptoms Rest pain, new-onset, or increasing pattern Prolonged chest pain Prolonged chest pain
Duration Often >20 minutes >20 minutes >20 minutes
ECG May show transient ST depression or T-wave changes ST depression, T-wave inversion ST-segment elevation
Biomarkers Normal Elevated Elevated
Pathophysiology Plaque disruption with non-occlusive thrombus Partial occlusion with myocardial necrosis Complete occlusion
Mortality Risk Lower Intermediate Higher

Clinical Implications and Management Considerations

  • The diagnosis of ACS should be made promptly as it has significant implications for morbidity and mortality 3
  • Early risk stratification is essential for determining appropriate management strategies 4
  • Patients with STEMI require immediate reperfusion therapy (ideally within 120 minutes) 3
  • High-risk patients with NSTE-ACS benefit from an early invasive strategy with coronary angiography within 24-48 hours 3
  • Pharmacological therapy typically includes:
    • Dual antiplatelet therapy (aspirin plus P2Y12 inhibitor like clopidogrel) 5
    • Anticoagulation
    • Consideration of adjunctive therapies (beta-blockers, ACE inhibitors, statins) 4

Important Considerations

  • A normal ECG does not exclude ACS; approximately 40% of patients with NSTE-ACS may have neither ST-segment depression nor T-wave inversion 1, 2
  • Women, elderly patients, and those with diabetes may present with atypical symptoms 2
  • Less common causes of myocardial ischemia include coronary artery spasm, embolism, and dissection 1
  • The pathophysiology of ACS is dynamic, and patients can rapidly progress from one clinical condition to another during evaluation and treatment 1

Understanding the spectrum of ACS is crucial for prompt diagnosis and appropriate management to reduce morbidity and mortality associated with these conditions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Coronary Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of acute coronary syndrome: an evidence-based update.

Journal of the American Board of Family Medicine : JABFM, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.